tradingkey.logo
tradingkey.logo
検索

Nyxoah SA

NYXH
ウォッチリストに追加
1.720USD
-0.060-3.37%
終値 07/02, 13:00ET15分遅れの株価
74.01M時価総額
損失額直近12ヶ月PER

詳細情報 Nyxoah SA 企業名

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Nyxoah SAの企業情報

企業コードNYXH
会社名Nyxoah SA
上場日Sep 18, 2020
最高経営責任者「CEO」Taelman (Olivier)
従業員数- -
証券種類Ordinary Share
決算期末Sep 18
本社所在地Rue Edouard Belin 12
都市MONT-SAINT-GUIBERT
証券取引所NASDAQ OMX - NASDAQ BASIC
Belgium
郵便番号1435
電話番号3226121755
ウェブサイトhttps://www.nyxoah.com/
企業コードNYXH
上場日Sep 18, 2020
最高経営責任者「CEO」Taelman (Olivier)

Nyxoah SAの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Francis Kim
Mr. Francis Kim
Chief Regulatory and Quality Officer
Chief Regulatory and Quality Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--

よくある質問

Nyxoah SAの上位5名の株主は誰ですか?

Nyxoah SAの上位5名の株主は以下のとおりです。Mr. Robert Taub

Nyxoah SA(NYXH)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Nyxoah SAの株式を保有している機関は79社あり、保有株式の総市場価値は約9.38Mで、全体の21.47%を占めています。2025Q4と比較して、機関の持ち株は-824223.00増加しています。